

| Á¦¸ñ | [FDA] New and Revised Draft GMP Guidances FDA is planning to publish 2017 | ||
|---|---|---|---|
| µî·ÏÀÏ | 2017-02-08 | Á¶È¸¼ö | 2,365 |
| ÷ºÎÆÄÀÏ | |||
| ³»¿ë | ¾È³çÇϼ¼¿ä. GMPSchoolÀÔ´Ï´Ù. FDA¿¡¼ »õ·Ó°Ô °³Á¤µÈ GMP Guidance ÃʾÈÀÌ 2017³â¿¡ ¹ß°£µÉ ¿¹Á¤ÀÔ´Ï´Ù. ------------------------------------------------------------------------------------------------------------- The U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) has published a Guidance Agenda with planned new and revised Draft Guidances for the calendar year 2017. Amongst these documents are a few which might be interesting for the GMP area, for example:
The items of the Guidance Agenda: New & Revised Draft Guidances CDER is Planning to Publish During Calendar Year 2017 reflect draft and revised draft guidances under development as of the date of FDA's posting. So there might be more to come. |
||
| ÀÌÀü±Û | [MFDS] ¡¸´ëÇѹα¹¾àÀü¿ÜÇѾà(»ý¾à)±Ô°ÝÁý¡¹ÀϺΰ³Á¤°í½Ã |
|---|
| ´ÙÀ½±Û | [FDA] Nonproprietary Naming of Biological Products ¹ßÇà |
|---|